News – Page 2742
-
News
news in brief The Medical Devices Agency
The Medical Devices Agency dealt with 6,125 adverse incident reports and issued 42 warning notices in 1998-99, according to its annual report. The number of adverse incident reports has increased by 60 per cent in four years.
-
News
news in brief The Fifth Annual Report and Accounts
The Fifth Annual Report and Accounts of the Medical Devices Agency. The Stationery Office. £13.75.
-
News
news in brief A Newcastle hospital
A Newcastle hospital has begun a pilot scheme to electronically tag 'confused and vulnerable' patients, triggered by the death of a patient who was not found until 10 hours after his disappearance. The three-month trial on one ward of the Royal Victoria Infirmary will attach the 'discreet devices' to patients ...
-
News
news in brief The King's Fund
The King's Fund is working with local groups in Greater Manchester, Sheffield and London to improve rehabilitation services for elderly people. The programme includes work with Trafford South primary care group, which is using workshops to help reshape existing services.
-
News
news in brief Liberal Democrat health spokesman Simon Hughes
Liberal Democrat health spokesman Simon Hughes has launched care standards for people with multiple sclerosis living in residential and nursing homes, drawn up by Leonard Cheshire and the Multiple Sclerosis Society. They call for residents to have a role in running homes and give advice on staff recruitment and training, ...
-
News
news in brief People with MS
People with MS in Long-term Care: good practice guidelines for service providers. Welfare Services Department, Multiple Sclerosis Society, 25 Effie Road, Fulham, London SW6 1EE. Free.
-
News
news in brief Buckinghamshire health authority
Buckinghamshire health authority has announced that it is spending a further £130,000 on beta interferon treatment this year, allowing another eight multiple sclerosis patients to be treated, doubling the number treated. Patients had protested about the limited availability of the drug in Buckinghamshire.